The spanish national cutaneous melanoma registry. Tumour characteristics at diagnosis: 15 years of experience;Registro nacional de melanoma cutáneo. Características del tumor en el momento del diagnóstico: 15 años de experiencia

Actas Dermo-Sifiliograficas

Volumn 104, Issue 9, 2013, Pages 789-799

  Rios L ^a   Nagore, E ^b   Lopez J L ^c   Redondo, P ^d   Marti R M ^e   Fernandez De Misa R ^f   Soler, B ^g  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e HOSPITAL ARNAU DE VILANOVA   (Spain)

^f HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^g AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Cancer; Epidemiology; Melanoma; Spain

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER REGISTRY; CROSS-SECTIONAL STUDY; CUTANEOUS MELANOMA; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LEG; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MELANOMA; OBSERVATIONAL STUDY; REGIONAL METASTASIS; SEX DIFFERENCE; SKIN BIOPSY; SPAIN; TRUNK; ULCER; ADOLESCENT; AGED; CÁNCER; CHILD; EPIDEMIOLOGÍA; EPIDEMIOLOGY; ESPAÑA; MIDDLE AGED; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; REGISTER; TIME; VERY ELDERLY; YOUNG ADULT;

CÁNCER; CANCER; EPIDEMIOLOGÍA; EPIDEMIOLOGY; ESPAÑA; MELANOMA; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; REGISTRIES; SPAIN; TIME FACTORS; YOUNG ADULT;

EID: 84886722157     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2013.02.003     Document Type: Article

References (33)

1. Cabanes Domenech A, Pérez-Gómez B, Aragonés N, Pollán M, López-Abente G. La situación del cáncer en España, 1975-2006. Área de Epidemiología Ambiental y Cáncer, Centro Nacional de Epidemiología ISCIII. 2009. Madrid. Disponible en: http://www.isciii.es/ISCIII/es/contenidos/fd-publicaciones- isciii/fd-documentos/SituacionCancerenEspana1975-2006-2010.pdf
2. D.M. Oarkin, S.L. Whelan, and J. Ferlay Cancer in five continents vol. VIII 1997 IARC Scientific Publication Lyon N. 143
3. J. Ferlay, R.J. Black, and S.L. Whelan Electronic database of cancer incidente in five continents VII 1997 IARCWHO Lyon
4. S. Sáenz, J. Conejo-Mir, and A. Cayuela Epidemiología del melanoma en España Actas Dermosifiliogr 96 2005 411 418
5. I.E. Ardanaz, C. Moreno, and M.E. Pérez de Rada Incidencia y mortalidad por cáncer en Navarra, 1993-1997. Tendencia en los últimos 25 años. Registro de Cáncer de Navarra. Sección de enfermedades no transmisibles y estadísticas vitales An Sist Sanit Navar 24 2001 339 362
6. V. Moreno, J.R. González, M. Soler, F.X. Bosch, M. Kogevinas, and J.M. Borràs Estimación de la incidencia de cáncer en España: periodo 1993-1996 Gac Sanit 15 2001 380 388
7. J.M. Ródenas, M. Delgado, and M.T. Herranz Sun exposure, pigmentary traits and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population Cancer Causes Control 7 1996 275 283
8. R. Ocaña-Riola, C. Martínez-García, and S. Serrano Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985-1992 Eur J Epidemiol 17 2001 169 174
9. A. Nieto, M. Ruiz-Ramos, L. Andel-Kader, M. Conde, and F. Camacho Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98 Br J Dermatol 148 2003 110 116
10. F. Berrino, R. Capocaccia, and J. Esteve Survival of cancer patients in Europe: the EUROCARE-2 Study 1999 IARC Lyon
11. M. Sant, T. Aareleid, F. Berrino, M. Bielska Lasota, P.M. Carli, and J. Faivre EUROCARE- 3: Survival of cancer patients diagnosed 1990-94 - results and commentary Ann Oncol 14 Suppl 5 2003 v61 v118
12. E. De Vries, and J.W. Coebergh Cutaneous malignant melanoma in Europe Eur J Cancer 40 2004 2355 2366
13. C. Navarro, C. Martos, E. Ardanaz, J. Galceran, I. Izarzugaza, R. Peris-Bonet for the Spanish Cancer Registries Working Group Population-based cancer registries in Spain and their role in cancer control Ann Oncol 21 Suppl 3 2010 iii3 iii13
14. J.A. Avilés, P. Lázaro, and M. Lecona Epidemiología y supervivencia del melanoma cutáneo en España: estudio de 552 casos Rev Clin Esp 2006 1994-2003 319 325
15. Gliklich RE, Dreyer NA, editors. Registries for evaluating patient outcomes: A user's guide. Rockville, MD: Agency for Health Resarch and Quality. April 2007-December 2009.
16. F.J. De Abajo Iglesias, L. Feito Grande, J. Júdez Gutiérrez, M.C. Martín Arribas, B. Terracini, and T. Pàmpols Ros Directrices éticas sobre la creación y uso de registros con fines de investigación biomédica Rev Esp Salud Pública 82 2008 21 42
17. Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
18. J. Marcoval, A. Moreno, A. Jonar, E. Baumann, J. Graells, and M.I. Gallego Evolución del melanoma maligno cutáneo en los últimos 19 años en un hospital terciario de la cuenca mediterránea Actas Dermosifiliogr 9 2008 464 468
19. K.G. Lasithiotakis, U. Leiter, R. Gorkievicz, T. Eigentler, H. Breuninger, and G. Metzler The incidence and mortality of cutaneous melanoma in southern Germany. Trends by anatomic site and pathologic characteristics, 1976 to 2003 Cancer 107 2006 1331 1339
20. E. Nagore, V. Oliver, R. Botella-Estrada, S. Moreno-Picot, C. Guillén, and J.M. Fortea Clinicopathological analysis of 1,571 cutaneous malignant melanomas in Valencia, Spain: Factors related to tumour thickness Acta Derm Venereol 86 2006 50 56
21. S.A. Holme, S. Varma, M.M.U. Chowdhury, and D.L. Robert Audit of a melanoma screening day in the UK clinical results, participant satisfaction and perceived value Br J Dermatol 145 2001 784 788
22. M. Asin Llorca, J. Bañuls Roca, A. Berrocal Jaime, J. Giménez Climent, M. González Nebreda, and C. Guillen Barona Guía de prevención y tratamiento del melanoma 2006 Conselleria de Sanitat Generalitat Valenciana ISBN: 84-7579-425-4. Disponible en: http://www.ivo.es/uploads/Oncoguía-Melanoma.pdf
23. C. Garbe, G.R. McLeod, and P.G. Buettner Time trends of cutaneous melanoma in Queensland, Australia and Central Europe Cancer 89 2000 1269 1278
24. M.B. Lens, and M. Dawes Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma Br J Dermatol 150 2004 179 185
25. S. Gandini, F. Sera, M.S. Cattaruzza, P. Pasquini, O. Picconi, and P. Boyle Metaanalysis of risk factors for cutaneous melanoma: II. Sun exposure Eur J Cancer 41 2005 45 60
26. P.G. Lang Current concepts in the management of patients with melanoma Am J Clin Dermatol 3 2002 401 426
27. E.L. Rager, E.P. Bridgeford, and D.W. Ollila Cutaneous melanoma: Update on prevention, screening, diagnosis, and treatment Am Fam Physician 72 2005 269 276
28. P. Carli, V. de Giorgi, D. Palli, A. Maurichi, P. Mulas, and C. Orlandi Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma Arch Dermatol 139 2003 607 612
29. N.R. Abbasi, H.M. Shaw, D.S. Rigel, R.J. Friedman, W.H. McCarthy, and I. Osman Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria JAMA 292 2004 2771 2776
30. V. Criscione, and A. Weinstock Melanoma thickness trends in the United States, 1988-2006 J Invest Dermatol 130 2010 793 797
31. A. Tejera-Vaquerizo, M. Mendiola-Fernández, A. Fernándes-Orland, and E. Herrera-Ceballos Thick melanoma: the problem continues J Eur Acad Dermatol Venereol 2 2008 575 579
32. W. Liu, P. Dowling, W.K. Murray, G.A. McArthur, J.F. Thompson, and R. Wolfe Rate of growth in melanomas. Characteristics and associations of rapidily growing melanomas Arch Dermatol 142 2006 1551 1558
33. Mar V, Roberts H, Wolfe R, English DR, Kelly JW. Nodular melanoma: A distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. J Am Acad Dermatol. 2012;68:568-75.